Cargando…
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
PURPOSE: (123)I-2β-Carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane ((123)I-FP-CIT) dopamine transporter single photon emission computed tomography (DAT SPECT) and (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy can be used to assist in the diagnosis of patients with dement...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679785/ https://www.ncbi.nlm.nih.gov/pubmed/26233438 http://dx.doi.org/10.1007/s00259-015-3146-y |
_version_ | 1782405582638022656 |
---|---|
author | Shimizu, Soichiro Hirao, Kentaro Kanetaka, Hidekazu Namioka, Nayuta Hatanaka, Hirokuni Hirose, Daisuke Fukasawa, Raita Umahara, Takahiko Sakurai, Hirohumi Hanyu, Haruo |
author_facet | Shimizu, Soichiro Hirao, Kentaro Kanetaka, Hidekazu Namioka, Nayuta Hatanaka, Hirokuni Hirose, Daisuke Fukasawa, Raita Umahara, Takahiko Sakurai, Hirohumi Hanyu, Haruo |
author_sort | Shimizu, Soichiro |
collection | PubMed |
description | PURPOSE: (123)I-2β-Carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane ((123)I-FP-CIT) dopamine transporter single photon emission computed tomography (DAT SPECT) and (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy can be used to assist in the diagnosis of patients with dementia with Lewy bodies (DLB). We compared the diagnostic value of these two methods in differentiating DLB from Alzheimer’s disease (AD). Furthermore, we evaluated whether a combination of DAT SPECT and MIBG myocardial scintigraphy would provide a more useful means of differentiating between DLB and AD. METHODS: Patients with AD (n = 57) and patients with DLB (n = 76) who underwent both DAT SPECT and MIBG myocardial scintigraphy were enrolled. The sensitivity, specificity, and accuracy of both methods as well as their combination for differentiating DLB from AD were calculated. Moreover, we examined whether symptoms of the patients with DLB were associated with the patterns of the abnormalities displayed on DAT SPECT and MIBG myocardial scintigraphy. RESULTS: The sensitivity and specificity of differentiating DLB from AD were 72.4 and 94.4 % by the heart to mediastinum ratio of MIBG uptake, 88.2 and 88.9 % by the specific binding ratio on DAT SPECT, and 96.1 and 90.7 % by their combination, respectively. The combined use of DAT SPECT and MIBG myocardial scintigraphy enabled more accurate differentiation between DLB and AD compared with either DAT SPECT or MIBG myocardial scintigraphy alone. There was a significantly higher frequency of parkinsonism in the abnormal DAT SPECT group than the normal DAT SPECT group. On the other hand, there was a higher frequency of the appearance of rapid eye movement (REM) sleep behavior disorder in the abnormal MIBG uptake group than the normal MIBG uptake group. CONCLUSION: These results suggested that using a combination of these scintigraphic methods is a useful and practical approach to differentiate DLB from AD. |
format | Online Article Text |
id | pubmed-4679785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-46797852015-12-22 Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease Shimizu, Soichiro Hirao, Kentaro Kanetaka, Hidekazu Namioka, Nayuta Hatanaka, Hirokuni Hirose, Daisuke Fukasawa, Raita Umahara, Takahiko Sakurai, Hirohumi Hanyu, Haruo Eur J Nucl Med Mol Imaging Original Article PURPOSE: (123)I-2β-Carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane ((123)I-FP-CIT) dopamine transporter single photon emission computed tomography (DAT SPECT) and (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy can be used to assist in the diagnosis of patients with dementia with Lewy bodies (DLB). We compared the diagnostic value of these two methods in differentiating DLB from Alzheimer’s disease (AD). Furthermore, we evaluated whether a combination of DAT SPECT and MIBG myocardial scintigraphy would provide a more useful means of differentiating between DLB and AD. METHODS: Patients with AD (n = 57) and patients with DLB (n = 76) who underwent both DAT SPECT and MIBG myocardial scintigraphy were enrolled. The sensitivity, specificity, and accuracy of both methods as well as their combination for differentiating DLB from AD were calculated. Moreover, we examined whether symptoms of the patients with DLB were associated with the patterns of the abnormalities displayed on DAT SPECT and MIBG myocardial scintigraphy. RESULTS: The sensitivity and specificity of differentiating DLB from AD were 72.4 and 94.4 % by the heart to mediastinum ratio of MIBG uptake, 88.2 and 88.9 % by the specific binding ratio on DAT SPECT, and 96.1 and 90.7 % by their combination, respectively. The combined use of DAT SPECT and MIBG myocardial scintigraphy enabled more accurate differentiation between DLB and AD compared with either DAT SPECT or MIBG myocardial scintigraphy alone. There was a significantly higher frequency of parkinsonism in the abnormal DAT SPECT group than the normal DAT SPECT group. On the other hand, there was a higher frequency of the appearance of rapid eye movement (REM) sleep behavior disorder in the abnormal MIBG uptake group than the normal MIBG uptake group. CONCLUSION: These results suggested that using a combination of these scintigraphic methods is a useful and practical approach to differentiate DLB from AD. Springer Berlin Heidelberg 2015-08-02 2016 /pmc/articles/PMC4679785/ /pubmed/26233438 http://dx.doi.org/10.1007/s00259-015-3146-y Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Shimizu, Soichiro Hirao, Kentaro Kanetaka, Hidekazu Namioka, Nayuta Hatanaka, Hirokuni Hirose, Daisuke Fukasawa, Raita Umahara, Takahiko Sakurai, Hirohumi Hanyu, Haruo Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease |
title | Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease |
title_full | Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease |
title_fullStr | Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease |
title_full_unstemmed | Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease |
title_short | Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease |
title_sort | utility of the combination of dat spect and mibg myocardial scintigraphy in differentiating dementia with lewy bodies from alzheimer’s disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679785/ https://www.ncbi.nlm.nih.gov/pubmed/26233438 http://dx.doi.org/10.1007/s00259-015-3146-y |
work_keys_str_mv | AT shimizusoichiro utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT hiraokentaro utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT kanetakahidekazu utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT namiokanayuta utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT hatanakahirokuni utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT hirosedaisuke utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT fukasawaraita utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT umaharatakahiko utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT sakuraihirohumi utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease AT hanyuharuo utilityofthecombinationofdatspectandmibgmyocardialscintigraphyindifferentiatingdementiawithlewybodiesfromalzheimersdisease |